CEA level was correlated with the mutation detection rate of EGFR in plasma (r = 0.39, p < 0.05, Figure 4A), and no more associations of driver gene mutations with serum tumor markers were observed (Figure 4A; Figure S8). The gene discussed is CEACAM5; the disease is neoplasm.